Nyxoah S.A.
NASDAQ: NYXH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Olivier Taelman
- Employees
- 163
- Headquarters
- Mont-Saint-Guibert, Belgium
- IPO year
- 2021
- Market cap
- $64.2M
- Website
- https://www.nyxoah.com
Loading NYXH…
Loading profile data…Frequently asked questions about NYXH
What does Nyxoah S.A. (NYXH) do?
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 20...
Where does NYXH trade?
Nyxoah S.A. (NYXH) trades on the NASDAQ.
What sector is NYXH in?
Nyxoah S.A. (NYXH) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of Nyxoah S.A.?
Olivier Taelman is the chief executive officer of Nyxoah S.A. (NYXH).
Where is Nyxoah S.A. headquartered?
Nyxoah S.A. is headquartered in Belgium.
Does NYXH pay a dividend?
Nyxoah S.A. (NYXH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NYXH go public?
Nyxoah S.A. (NYXH) completed its initial public offering in 2021.